
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.270 | 2.270 | 0.000 |
Shares | 97.730 | 97.730 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.079 | 18.875 |
Price to Book | 5.225 | 3.090 |
Price to Sales | 5.327 | 2.308 |
Price to Cash Flow | 18.755 | 12.241 |
Dividend Yield | 1.414 | 2.014 |
5 Years Earnings Growth | 8.812 | 9.805 |
Name | Net % | Category Average |
---|---|---|
Technology | 32.450 | 24.559 |
Financial Services | 25.180 | 16.898 |
Consumer Defensive | 13.620 | 7.148 |
Healthcare | 12.040 | 12.024 |
Industrials | 8.720 | 12.121 |
Consumer Cyclical | 4.390 | 10.353 |
Communication Services | 3.600 | 8.257 |
Number of long holdings: 38
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 8.88 | 509.28 | -0.93% | |
SAP | DE0007164600 | 7.60 | 229.980 | -0.61% | |
Visa A | US92826C8394 | 6.39 | 348.29 | +1.45% | |
L'Oreal | FR0000120321 | 4.98 | 370.00 | 0.00% | |
Aon | IE00BLP1HW54 | 4.29 | 357.72 | +1.23% | |
Relx | GB00B2B0DG97 | 3.72 | 3,428.00 | +0.82% | |
Coca-Cola | US1912161007 | 3.64 | 67.05 | +0.37% | |
Alphabet A | US02079K3059 | 3.52 | 242.54 | -0.66% | |
Roper Technologies | US7766961061 | 3.46 | 512.40 | -0.06% | |
P&G | US7427181091 | 3.35 | 147.75 | +0.17% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.29B | 0.87 | 8.54 | 9.87 | ||
Adamant Medtech I USD | 1.29B | 1.40 | 9.30 | 10.65 | ||
EDM Intl S American Growth A USD | 314.34M | 4.80 | 13.71 | 11.18 | ||
LU1811047247 | 180.15M | -2.21 | 1.27 | - | ||
LU1811047593 | 180.15M | -2.61 | 0.57 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review